Word

ACORA

Status

Dead

Status Code

606

Status Date

Monday, November 27, 2023

Serial Number

90535685

Mark Type

4000

Filing Date

Friday, February 19, 2021

Published for Opposition

Tuesday, March 1, 2022

Abandoned Date

Monday, November 27, 2023

Trademark Owner History

Axcella Health Inc. - Owner At Publication

Classifications

5 Dietary supplements for human and non-human use, dietary supplements for restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; nutraceuticals for treating or restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints; dietary and nutritional supplements

1 Proteins and biochemicals in the nature of polypeptides, peptides, amino acids, and small molecules in the nature of organic compounds and metabolites for use in scientific and medical research; nutrients and nutritive products, namely, proteins and biochemicals in the nature of polypeptides, peptides, amino acids, and small molecules in the nature of organic compounds and metabolites for use in the manufacture of beverages, food products and food supplements for human and non-human use; proteins for the food industry in the nature of proteins, polypeptides, peptides, and amino acids for use in the manufacture of pharmaceutical preparations, medicines, medical foods, nutraceuticals, and dietary and nutritional foods and supplements; biochemicals, namely, small molecules in the nature of organic compounds and metabolites for use in the manufacture of pharmaceutical preparations, medical foods, nutraceuticals, and dietary and nutritional foods and supplements; biochemicals for in vitro and in vivo scientific research

42 Research and development of medical foods, nutraceuticals, and dietary and nutritional foods and supplements for others; scientific and product research and development of proteins, polypeptides, peptides, amino acids, and small molecules for restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement

Trademark Events

Nov 27, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

Nov 27, 2023

Abandonment - No Use Statement Filed

Apr 25, 2023

Notice Of Approval Of Extension Request E-Mailed

Apr 21, 2023

Sou Extension 2 Granted

Apr 21, 2023

Sou Extension 2 Filed

Apr 21, 2023

Sou Teas Extension Received

Oct 26, 2022

Notice Of Approval Of Extension Request E-Mailed

Oct 24, 2022

Sou Extension 1 Granted

Oct 24, 2022

Sou Extension 1 Filed

Oct 24, 2022

Sou Teas Extension Received

Apr 26, 2022

Noa E-Mailed - Sou Required From Applicant

Mar 1, 2022

Official Gazette Publication Confirmation E-Mailed

Mar 1, 2022

Published For Opposition

Feb 9, 2022

Notification Of Notice Of Publication E-Mailed

Jan 25, 2022

Approved For Pub - Principal Register

Dec 7, 2021

Teas/Email Correspondence Entered

Dec 6, 2021

Correspondence Received In Law Office

Dec 6, 2021

Teas Response To Office Action Received

Sep 21, 2021

Notification Of Non-Final Action E-Mailed

Sep 21, 2021

Non-Final Action E-Mailed

Sep 21, 2021

Non-Final Action Written

Sep 14, 2021

Assigned To Examiner

May 20, 2021

New Application Office Supplied Data Entered

Feb 23, 2021

New Application Entered